{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T18:37:44Z","timestamp":1767206264793,"version":"build-2238731810"},"reference-count":63,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:00:00Z","timestamp":1744588800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Prostate cancer (PCa) in the transition zone (TZ) is uncommon and often poses challenges for early diagnosis, but its genomic determinants and therapeutic vulnerabilities remain poorly characterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Tumor mutational landscape was characterized in nine patients with TZ PCa, identifying somatic variants through whole-exome sequencing (WES). Novel candidate variants relevant to driver gene were selected using rare-variant burden analysis. Kaplan-Meier curves with log-rank testing and Cox regression models were applied to evaluate the prognostic significance of selected mutant driver gene and clinicopathological characteristics in a cohort of 132 patients with TZ PCa. Significant prognostic determinants were integrated into a validated nomogram for individualized prediction of 3-, 4-, and 5-year biochemical recurrence-free survival (BRFS) and overall survival (OS) probabilities. Eight machine learning algorithms were employed to develop BRFS and OS prediction models in a cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 5,036 somatic single nucleotide variants (SNVs) and 587 somatic insertion and deletion (INDELs) were discovered. Among eight driver gene mutations which were verified through Sanger sequencing, TET2 gene, with high mutation frequency and potential targeted drug relevance (bromodomain inhibitors and DOT1L inhibitors) was selected for further validation. Retrospective cohort study demonstrated that TET2 mutant status was significantly associated with Gleason score (p = 0.004) and distant metastasis (p = 0.002). Furthermore, TET2 mutant status was significantly correlated with inferior BRFS and OS and served as an independent predictor. Comparative evaluation of eight algorithms revealed the GBM model achieved superior discriminative ability for BRFS (AUC for 3-year: 0.752, 4-year: 0.786, 5-year: 0.796). The predictive model based on the GBM machine learning algorithm achieved the best predictive performance for OS (AUC for 3-year: 0.838, 4-year: 0.915, 5-year: 0.868). The constructed predictive nomogram provided evidence that TET2 mutant status integration conferred statistically significant improvements in model accuracy and clinical predictive value.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study elucidated the distinct genetic basis of prostate cancer in the transition zone and identified TET2 mutation as an independent prognostic determinant in TZ PCa. However, the limited sample size of this study necessitates cautious interpretation of these findings, and further validation in larger cohorts is warranted to confirm their generalizability.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1568665","type":"journal-article","created":{"date-parts":[[2025,4,14]],"date-time":"2025-04-14T00:10:27Z","timestamp":1744589427000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["TET2 gene mutation status associated with poor prognosis of transition zone prostate cancer: a retrospective cohort study based on whole exome sequencing and machine learning models"],"prefix":"10.3389","volume":"16","author":[{"given":"Yutong","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ailing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziping","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoying","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaochen","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoyun","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Honglong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,14]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.semnuclmed.2016.07.002","article-title":"Diagnostic and therapeutic strategies for prostate cancer","volume":"46","author":"Nguyen-Nielsen","year":"2016","journal-title":"Semin Nucl Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000000804","article-title":"Tumor location and pathological features of latent and incidental prostate cancer in contemporary Japanese men","volume":"204","author":"Inaba","year":"2020","journal-title":"J Urol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1097\/00000478-198812000-00001","article-title":"Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread","volume":"12","author":"McNeal","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1101\/gad.16962311","article-title":"The Cyclin K\/Cdk12 complex maintains genomic stability via regulation of expression of DNA damage response genes","volume":"25","author":"Blazek","year":"2011","journal-title":"Genes Dev"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20793","article-title":"Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging","volume":"25","author":"Tanimoto","year":"2007","journal-title":"J Magn Reson Imaging"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2018.11.031","article-title":"Detection of individual prostate cancer foci via multiparametric magnetic resonance imaging","volume":"75","author":"Johnson","year":"2019","journal-title":"Eur Urol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.12120281","article-title":"Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging","volume":"266","author":"Hoeks","year":"2013","journal-title":"Radiology"},{"key":"B9","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/1097-0142(19920701)70:1+&lt;291::aid-cncr2820701317<3.0.co;2-4","article-title":"The association of benign prostatic hyperplasia and cancer of the prostate","volume":"70","author":"Bostwick","year":"1992","journal-title":"Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/02841850802508959","article-title":"Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer","volume":"49","author":"Yoshizako","year":"2008","journal-title":"Acta Radiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2011.07.007","article-title":"Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies","volume":"56","author":"Marquardt","year":"2012","journal-title":"J Hepatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1038\/s41568-021-00377-7","article-title":"Mutational signatures: emerging concepts, caveats and clinical applications","volume":"21","author":"Koh","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btp324","article-title":"Fast and accurate short read alignment with Burrows-Wheeler transform","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btu314","article-title":"SAMBLASTER: fast duplicate marking and structural variant read extraction","volume":"30","author":"Faust","year":"2014","journal-title":"Bioinformatics"},{"key":"B15","doi-asserted-by":"publisher","first-page":"11.10.1","DOI":"10.1002\/0471250953.bi1110s43","article-title":"From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline","volume":"43","author":"Van der Auwera","year":"2013","journal-title":"Curr Protoc Bioinf"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.1.308","article-title":"dbSNP: the NCBI database of genetic variation","volume":"29","author":"Sherry","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"B17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","article-title":"An integrated map of genetic variation from 1,092 human genomes","volume":"491","author":"Abecasis","year":"2012","journal-title":"Nature"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.2514","article-title":"Sensitive detection of somatic point mutations in impure and heterogeneous cancer samples","volume":"31","author":"Cibulskis","year":"2013","journal-title":"Nat Biotechnol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bts271","article-title":"Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs","volume":"28","author":"Saunders","year":"2012","journal-title":"Bioinformatics"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkq929","article-title":"COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer","volume":"39","author":"Forbes","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1101\/gr.134635.111","article-title":"MuSiC: identifying mutational significance in cancer genomes","volume":"22","author":"Dees","year":"2012","journal-title":"Genome Res"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/s0302-2838(01)00021-5","article-title":"Tumour grade, proliferation, apoptosis, microvessel density, p53, and bcl-2 in prostate cancers: differences between tumors located in the transition zone and in the peripheral zone","volume":"41","author":"Erbersdobler","year":"2002","journal-title":"Eur Urol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1038\/s41585-021-00524-7","article-title":"Prostate zones and cancer: lost in transition","volume":"19","author":"Ali","year":"2022","journal-title":"Nat Rev Urol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-5347(17)38003-5","article-title":"A comparison of the morphological features of cancer arising in the transition zone and in the peripheral zone of the prostate","volume":"146","author":"Greene","year":"1991","journal-title":"J Urol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1097\/PAS.0b013e318172ee97","article-title":"Do prostatic transition zone tumors have a distinct morphology","volume":"32","author":"Garcia","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0090-4295(96)00254-3","article-title":"Limitations of transition zone needle biopsy findings in the prediction of transition zone cancer and tissue composition of benign nodular hyperplasia","volume":"48","author":"McNeal","year":"1996","journal-title":"Urology"},{"key":"B27","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer","volume":"578","author":"Alexandrov","year":"2020","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat Genet"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1007\/s40520-023-02466-z","article-title":"Advanced age is an independent prognostic factor of disease progression in high-risk prostate cancer: results in 180 patients treated with robot-assisted radical prostatectomy and extended pelvic lymph node dissection in a tertiary referral center","volume":"35","author":"Porcaro","year":"2023","journal-title":"Aging Clin Exp Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2017.05.051","article-title":"Enhanced rate of acquisition of point mutations in mouse intestinal adenomas compared to normal tissue","volume":"19","author":"Lugli","year":"2017","journal-title":"Cell Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.7150\/jca.29481","article-title":"Prognostic significance of young age and non-bone metastasis at diagnosis in patients with metastatic prostate cancer: a SEER population-based data analysis","volume":"10","author":"Guo","year":"2019","journal-title":"J Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5173\/ceju.2019.1974","article-title":"Age and aggressiveness of prostate cancer: analysis of clinical and pathological characteristics after radical prostatectomy for men with localized prostate cancer","volume":"72","author":"Milonas","year":"2019","journal-title":"Cent Eur J Urol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1186\/s12920-021-01121-8","article-title":"Mutational signatures among young-onset testicular cancers","volume":"14","author":"Mealey","year":"2021","journal-title":"BMC Med Genomics"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.376","article-title":"TET2 binds the androgen receptor and loss is associated with prostate cancer","volume":"36","author":"Nickerson","year":"2017","journal-title":"Oncogene"},{"key":"B36","doi-asserted-by":"publisher","first-page":"8219","DOI":"10.1038\/ncomms9219","article-title":"TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression","volume":"6","author":"Takayama","year":"2015","journal-title":"Nat Commun"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1968210","article-title":"CDK12 is a transcription elongation-associated CTD kinase, the metazoan ortholog of yeast Ctk1","volume":"24","author":"Bartkowiak","year":"2010","journal-title":"Genes Dev"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/j.cell.2018.04.034","article-title":"Inactivation of CDK12 delineates a distinct immunogenic class of advanced prostate cancer","volume":"173","author":"Wu","year":"2018","journal-title":"Cell"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1200\/po.19.00399","article-title":"CDK12-altered prostate cancer: clinical features and therapeutic outcomes to standard systemic therapies, poly (ADP-ribose) polymerase inhibitors, and PD-1 inhibitors","volume":"4","author":"Antonarakis","year":"2020","journal-title":"JCO Precis Oncol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01899-y","article-title":"MUC1-C activates the PBAF chromatin remodeling complex in integrating redox balance with progression of human prostate cancer stem cells","volume":"40","author":"Hagiwara","year":"2021","journal-title":"Oncogene"},{"key":"B41","article-title":"Loss of ARID1A, ARID1B, and ARID2 expression during progression of gastric cancer","volume":"35","author":"Aso","year":"2015","journal-title":"Anticancer Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-022-00505-x","article-title":"ARID2 suppression promotes tumor progression and upregulates cytokeratin 8, 18 and \u03b2-4 integrin expression in TP53-mutated tobacco-related oral cancer and has prognostic implications","volume":"29","author":"Shukla","year":"2022","journal-title":"Cancer Gene Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1914937117","article-title":"Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis","volume":"117","author":"Jiang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-023-02216-y","article-title":"Transcription factor NKX2-1 drives serine and glycine synthesis addiction in cancer","volume":"128","author":"Heylen","year":"2023","journal-title":"Br J Cancer"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2021.1967064","article-title":"Circular RNA hsa_circ_0075542 acts as a sponge for microRNA-1197 to suppress Malignant characteristics and promote apoptosis in prostate cancer cells","volume":"12","author":"Han","year":"2021","journal-title":"Bioengineered"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omz122","article-title":"Alveolar soft part sarcoma mimics prostate cancer metastasis","volume":"2019","author":"Principe","year":"2019","journal-title":"Oxf Med Case Rep"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa290","article-title":"SPEG: a key regulator of cardiac calcium homeostasis","volume":"117","author":"Campbell","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.045791","article-title":"Loss of SPEG inhibitory phosphorylation of ryanodine receptor type-2 promotes atrial fibrillation","volume":"142","author":"Campbell","year":"2020","journal-title":"Circulation"},{"key":"B49","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/cbf.3694","article-title":"Copy number and expression of CEP89, a protein required for ciliogenesis, are increased and predict poor prognosis in patients with ovarian cancer","volume":"40","author":"Berkel","year":"2022","journal-title":"Cell Biochem Funct"},{"key":"B50","doi-asserted-by":"publisher","first-page":"65","DOI":"10.5527\/wjn.v7.i2.65","article-title":"Genetic defects in ciliary genes in autosomal dominant polycystic kidney disease","volume":"7","author":"Skalick\u00e1","year":"2018","journal-title":"World J Nephrol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/s41467-021-21860-7","article-title":"A noncanonical AR addiction drives enzalutamide resistance in prostate cancer","volume":"12","author":"He","year":"2021","journal-title":"Nat Commun"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2017.1393518","article-title":"BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations","volume":"26","author":"Markowski","year":"2017","journal-title":"Expert Opin Investig Drugs"},{"key":"B53","doi-asserted-by":"publisher","first-page":"e145459","DOI":"10.1172\/JCI145459","article-title":"BET bromodomain protein inhibition reverses chimeric antigen receptor extinction and reinvigorates exhausted T cells in chronic lymphocytic leukemia","volume":"131","author":"Kong","year":"2021","journal-title":"J Clin Invest"},{"key":"B54","doi-asserted-by":"publisher","first-page":"4153","DOI":"10.1038\/s41467-020-18013-7","article-title":"Histone methyltransferase DOT1L coordinates AR and MYC stability in prostate cancer","volume":"11","author":"Vatapalli","year":"2020","journal-title":"Nat Commun"},{"key":"B55","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2011.06.010","article-title":"MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L","volume":"20","author":"Bernt","year":"2011","journal-title":"Cancer Cell"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1101\/gad.276568.115","article-title":"Role of TET enzymes in DNA methylation, development, and cancer","volume":"30","author":"Rasmussen","year":"2016","journal-title":"Genes Dev"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.111703","article-title":"DOT1L regulates lipid biosynthesis and inflammatory responses in macrophages and promotes atherosclerotic plaque stability","volume":"41","author":"Willemsen","year":"2022","journal-title":"Cell Rep"},{"key":"B58","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1038\/s41421-023-00567-7","article-title":"TET2 is required to suppress mTORC1 signaling through urea cycle with therapeutic potential","volume":"9","author":"He","year":"2023","journal-title":"Cell Discovery"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1002\/pros.20282","article-title":"Possible role of adaptive mutation in resistance to antiandrogen in prostate cancer cells","volume":"65","author":"Hara","year":"2005","journal-title":"Prostate"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.22.1687","article-title":"Androgen receptor signaling in androgen-refractory prostate cancer","volume":"93","author":"Grossmann","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.7497\/j.issn.2095-3941.2014.04.007","article-title":"Sequential maximum androgen blockade (MAB) in minimally symptomatic prostate cancer progressing after initial MAB: two case reports","volume":"11","author":"Hingorani","year":"2014","journal-title":"Cancer Biol Med"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2019-0115","article-title":"Comprehensive analysis of AR alterations in circulating tumor DNA from patients with advanced prostate cancer","volume":"25","author":"Ledet","year":"2020","journal-title":"Oncologist"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0864-1","article-title":"Functional analysis of androgen receptor mutations that confer anti-androgen resistance identified in circulating cell-free DNA from prostate cancer patients","volume":"17","author":"Lallous","year":"2016","journal-title":"Genome Biol"}],"updated-by":[{"DOI":"10.3389\/fendo.2025.1738698","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000}}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1568665\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T13:53:50Z","timestamp":1765374830000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1568665\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,14]]},"references-count":63,"alternative-id":["10.3389\/fendo.2025.1568665"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1568665","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,14]]},"article-number":"1568665"}}